Advanced Medical Institute Inc. Announces Results for the Quarter Ended September 30, 2008.

SYDNEY, Australia -- Advanced Medical Institute Inc. (OTCBB:AVMD)(AMI), a leading provider of treatment for Erectile Dysfunction and Premature Ejaculation in Australia and New Zealand, has announced results for the quarter ended September 30, 2008. All figures are in U.S. Dollars.

For the quarter ended September 30, 2008, as compared to the same period in 2007:

* Total gross revenue increased 47.5% to $15,949,302 compared with gross revenue of $10,813,778 in the prior corresponding period. Revenue from its Premature Ejaculation treatment programs increased 41.7% to $7,504,889, revenue from its Erectile Dysfunction treatment programs increased 60.1% to $7,829,923 and revenue from its prostate treatment programs decreased 12.1% to $512,756.

* Unearned revenue increased by $1,263,773 to $6,476,016 during the twelve month period, an increase of 24.2%.

* Net income before tax was $488,993, compared with net income before tax of $148,673 in the prior corresponding period.

* Net income after tax was $114,646, compared with $(61,537) in the prior corresponding period.

As at June 30, 2008, cash and cash equivalents were $2,364,098, compared to $3,127,029 as at June 30, 2008.

As at October 31, 2008, the principal of the Company's secured loan was AUD1.839 million (approximately USD1.51 million).

"We are delighted with the continued growth in the Company's gross revenue and return to profitability over the last 12 months," said Dr. Jacov Vaisman, founder, president, CEO and chairman of the board of AVMD. "We are pleased that our Australian operations have experienced significant growth across all market segments and believe that our new United Kingdom operations will significantly add to profitability. We are also pleased to have reduced our secured debt by AUD900,000 (approximately USD810,000) over the last 12 months."

For more detailed information please see the attached table of results or refer to the Company's Annual Report on Form 10-K filed with the United States Securities and Exchange Commission.

About AMI

Advanced Medical Institute Inc., (OTCBB:AVMD), headquartered in Sydney, Australia, is a leading provider of treatment programs for erectile dysfunction and premature ejaculation in Australia and New Zealand. The Company operates more than 20 facilities in Australia, New Zealand, China and the United Kingdom. AVMD has more than 270 employees, including more than 50 medical personnel and, since its inception, has provided treatment to more than 400,000 customers. Advanced Medical Institute and its predecessor companies began arranging treatment programs for Premature Ejaculation and Erectile Dysfunction patients in 1993. For more information, visit the company's website at: http://www.avmd.com.au.

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward- looking statements are based on current expectations or beliefs, including, but not limited to, statements concerning the company's operations and financial performance and condition. For this purpose, statements that are not statements of historical fact may be deemed to be forward-looking statements. The company cautions that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others, the impact of competitive products and pricing; changes in consumer preferences and tastes or perceptions of health-related issues; effectiveness of advertising or market-spending programs; changes in laws and regulations; fluctuations in costs of production, foreign exchange and interest rates; and other factors as those discussed in the Company's reports filed with the Securities and Exchange Commission from time to time.

[TABLE OMITTED]